Become A Member Career CSR
CHP
  • +91-11-43007401
  • info@chp-f.com
  • Home
  • About us
    • Who we are
    • Vision & Mission
    • Charter
    • Advisors
    • Leadership Team
    • Members
  • Services
    • Market Access
    • Therapeutic Areas
    • Regulatory Affairs
      • Regulatory Compliance
    • Intellectual Property
    • Start ups
  • Focus
    • China
    • India
    • Japan
    • USA
    • Global
  • Media & Research
    • News Centre
    • Statistics & Quick Facts
    • Research Report
    • Media Contact
  • Gallery
  • Events
  • Contact Us
Industry News:
  • Opinion: Are we as unbiased as we think?
  • Longtime cancer doctor takes the helm at FDA
  • Charla Huber: Are we as unbiased as we think?
  • Mylan’s Pakistan Partner to Sell Covid-19 Drug Within Two Months
  • Central Maine business briefs: Andrew Zulieve to lead the Maine Bar Association Intellectual Property Division
  • Mylan (MYL) Invalidates Sanofi’s (SNY) Lantus SoloSTAR Device Patents in IPR Proceedings
  • Glenmark gets FDA nod for chlorzoxazone
  • The New NAFTA and the End of U.S. Leadership in Trade
  • Redesigning unemployment benefits: A social value-based benefit
  • US: FDA finds carcinogen in some versions of popular diabetes drug
  • FDA Finds Carcinogen in Some Versions of Popular Diabetes Drug
  • Back To Work Wash Hands Wash Face Immunity Protection Detox
  • Regulatory actions for May 27, 2020
  • FDA Finds Carcinogen in Some Versions of Popular Diabetes Drug
  • Clinical trial offers clues about why some metastatic prostate cancers do not respond to anti-androgen therapy
  • Promising researchers to receive funding through AGA Research Foundation Awards Program
  • Helium: An Abundant History and a Shortage Threatening Scientific Tools
  • FDA approves 2 drugs to combat COVID-19 shortages
  • ACNM Endorses MANA Health Policy Statement on Passport Denials
  • The Perennial Lessons To Learn From Public Health Policy Battles
  • Lu Qingguo, Chairman Of The National People’S Congress And Chairman Of Chenguang Biotechnology Group, Is Urgent To Forage The Feed.
  • Daewoong Pharmaceutical Acquires Halal Certification for ‘Easyef’ through Daewoong Infion
  • Does Jones Act protect national security?
  • Takeda’s Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer
  • Wired Next Fest, we start with Wired Health
  • Post PCI Bleeding Risk Definition Validated in Real-World Cohort
  • County’s DELCORA moves raise questions
  • Abbott Wins UK Government Contract to Supply Millions of Laboratory-Based IgG Antibody Tests
  • County’s DELCORA moves raise questions
  • Chinese lawmaker suggests improving medical science innovation
More News

News

  • Vitals – July 30, 2019 – Axios

    By Caitlin Owens Good morning. I regret to inform you that I am back from vacation, which means that you will no longer have Sam's intros... Tuesday July 30, 2019 | Axios
  • 4 Subtle Signs You’re Developing Diabetes

    Diabetes can sneak up on you. Tuesday July 30, 2019 | Pulse [GH]
  • The Best Gynaecologists In Lagos

    Lagos moms-to-be understand the struggle of trying to find gynaecologists from a pool of good doctors. The stress comes from trying to... Tuesday July 30, 2019 | Pulse.ng
  • Millicent Onyonyi Takes Over As Chief Executive At Ola Energy Kenya

    Millicent Onyonyi has been appointed the General Manager for Ola Energy (formerly OiLibya) Kenya to replace Duncan Murashiki at the end of... Tuesday July 30, 2019 | Kenya Broadcasting Corporation
  • Antifungal Drugs Market Key Companies Profile, Trends, Share And Growth Forecast 2022 – Merck & Co., Glaxo Smith Kline, Astellas Pharma, Sanofi, Abbott Laboratories, Bayer

    The report on “Antifungal Drugs Market” will help Major Players and the new entrants to understand scrutinize the market in detail. This... Tuesday July 30, 2019 | Honest Bussinessman
  • Expensive Gilead, Novartis Cancer Therapies Losing Patients To Experimental Treatments

    Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments By Deena... Tuesday July 30, 2019 | Sharenet
  • Breast Implants Market To Reach US$ 2,338.6 Mn By 2027 Led By Prominent Players Like Allergan, Mentor Worldwide LLC (J&J), GC Aesthetics, Sientra, POLYTECH Health & Aesthetics, Ideal Implant Incorporated, Silimed, Group Sebbib SAS

    According to a new market research study titled 'Breast Implants Market to 2027 - Global Analysis and Forecasts by Product, Applications,... Tuesday July 30, 2019 | Prsync.com
  • 4 Subtle Signs You’re Developing Diabetes

    Diabetes can sneak up on you. Tuesday July 30, 2019 | Pulse.ng
  • Coronary Stents Market To Witness Huge Growth In 2025 Led By Top Players Like Microport Scientific Corporation, Medtronic PLC, Biosensors International Group, Ltd., Abbott Laboratories, Vascular Concepts Limited

    According to a new market research study titled 'Coronary Stents Market to 2025 - Global Analysis and Forecasts by Type, by Absorption... Tuesday July 30, 2019 | Prsync.com
  • Endometrial Cancer: What To Know

      A form of uterine cancer, endometrial cancer is the most common cancer of the female reproductive organs.   Endometrial cancer starts... Tuesday July 30, 2019 | 1stnews
  • New Mother Catches Husband Eating Her Younger Sister

    When Agwata gave birth to her second born, her husband agreed that they host her younger sister Kerubo to help them with some chores.... Tuesday July 30, 2019 | Tuko
  • Antiemetics Market Analysis To 2027 – Abbott, Astellas Pharma, Aphios Corp, Aurobindo Pharma, Daiichi Sankyo Company, Eisai, Glaxosmithkline Plc, Helsinn Healthcare Sa, Heron Therapeutics, And Ipca Laboratories

    The report analyzes factors affecting Antiemetics market from both demand and supply side and further evaluates market dynamics effecting... Tuesday July 30, 2019 | Honest Bussinessman
  • Vascular Closure Device Market Survey 2019: Terumo Corporation, Abbott Laboratories, Cardinal Health, Inc. (Cordis), Cardiva Medical, Inc., Medtronic PLC, Morris Innovative

    The report analyzes factors affecting Vascular Closure Device Market from both demand and supply side and further evaluates market dynamics... Tuesday July 30, 2019 | Honest Bussinessman
  • Millicent Onyonyi Named Ola Energy’s New General Manager For Kenya

    Millicent Onyonyi has been appointed Ola Energy’s (formerly OiLibya) new General Manager for Kenya replacing Duncan Murashiki following... Tuesday July 30, 2019 | Khusoko
  • Professors (Clinical Sciences) At The Federal University Dutse (FUD)

    Federal University Dutse (FUD) invites applications from suitable qualified candidates for the position of Professor in the following... Tuesday July 30, 2019 | Latest Nigerian News
  • Lecturer I (Clinical Sciences) At The Federal University Dutse (FUD)

    Federal University Dutse (FUD) invites applications from suitable qualified candidates for the position of Lecturer I in the following... Tuesday July 30, 2019 | Latest Nigerian News
  • 雁栖健谈丨大健康创新项目路演总决赛完美谢幕

    [ 亿欧导读 ] “大健康创新项目路演总决赛落下帷幕,为期三天的“雁栖健谈”GIIS 2019第四届中国大健康产业升级峰会也完美画上句点。但是,大健康产业的发展与变革只有进行时没有完成时。 Tuesday July 30, 2019 | 亿欧网
  • A Discussion About Breast Implants

    Question: Are my breast implants safe? Answer: This is the question on the minds today for many women who have breast implants, and for... Tuesday July 30, 2019 | Palm Beach Post
  • 10 Ways To Make Yourself Poop First Thing In The Morning

    You know coffee's on this list. Tuesday July 30, 2019 | Health24.com
  • Allergan Announces Recall Of Textured Breast Cancer Over Associated Cancer Risk

    Medical cure agency Allergan has introduced a global remember of textured implants at the heels of the US Food and Drug Administration... Tuesday July 30, 2019 | News Live TV
  • Wall Street Cierra Mixto Pendiente De Resultados, China Y La Reserva Federal

    Nueva York, 29 jul (EFE).- Wall Street cerró este lunes en terreno mixto, con los mercados pendientes de los próximos desarrollos en el... Tuesday July 30, 2019 | Qué Pasa Mi Gente - Charlotte
  • Wall Street Cierra Mixto, Pendiente De China, Reserva Federal Y Resultados

    Nueva York, 29 jul (EFEUSA).- Wall Street cerró este lunes en terreno mixto, con los mercados pendientes de los próximos desarrollos en el... Tuesday July 30, 2019 | Latinx Today
  • Pfizer To Combine Off-patent Drug Business With Mylan

    NEW YORK – Pfizer announced Monday it will merge its off-patent drug business with generic drugmaker Mylan to create a global leader in... Tuesday July 30, 2019 | Business Breaking News
  • 4 Companies Pay California $70 Million For Delaying Drug Rollouts To Keep Prices High

    Four pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs... Monday July 29, 2019 | CNBC
  • Wall Street Cierra Mixto Pendiente De Resultados, China Y La Reserva Federal

    Wall Street cerró este lunes en terreno mixto, con los mercados pendientes de los próximos desarrollos en el negociación comercial con... Monday July 29, 2019 | Informe21.com
  • Wall Street Cierra Sesión Mixto Pendiente De Resultados China Y La Reserva Federal

    NUEVA YORK (EEUU).- Wall Street cerró este lunes en terreno mixto, con los mercados pendientes de los próximos desarrollos en la... Monday July 29, 2019 | Crónica Viva
  • Sun Pharma Launches Ezallor Sprinkle Rosuvastatin In The U.S. For People Who Have Difficulty Swallowing: Sun Pharmaceutical Industries Ltd.

    2019 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at Hospital & Nursing Home Daily -- Sun Pharmaceutical Industries Ltd.... Monday July 29, 2019 | Market Screener
  • Why Everyone Is Talking About Breast Implant Safety Right Now

    Your complete guide to recalls, "breast implant illness," and the conversation surrounding them. Monday July 29, 2019 | Allure Magazine
  • Pfizer, Mylan Deal Aimed At Boosting Drug Prices As Generics Struggle

    In a deal aimed at shoring up drug prices, pharmaceutical giant Pfizer's off-patent drug business, Upjohn, is set to merge with Mylan,... Monday July 29, 2019 | F3News
  • Pfizer To Merge Its Old Blockbuster-drug Unit With Mylan

    Pfizer Inc. plans to mix its company that sells older blockbuster drug treatments similar to Lipitor and Viagra with standard drugmaker... Monday July 29, 2019 | DailyHeralds
  • EpiPen Maker Mylan, Pfizer’s Upjohn Off-patent Drug Business To Merge

    CLOSE In a deal aimed toward shoring up drug fees, pharmaceutical enormous Pfizer's off-patent drug enterprise, Upjohn, is determined to... Monday July 29, 2019 | DailyHeralds
  • Pfizer To Combine Off-patent Drug Business With Mylan

    The combination will allow Pfizer to boost depressed sales through the loss of patent protection of certain drugs Pfizer announced Monday... Monday July 29, 2019 | Phys.org
  • FDA警告信:你公司未对每种组份样品进行鉴别检查……

    翻译:JULIA  来源:Julia法规翻译 Warning Letter 320-19-26    June 13, 2019   Mr. Shiv Shanker Asthana Director, Rxhomeo Private Limited Indradhanush,... Monday July 29, 2019 | 今天看啥
  • Erdafitinib In FGFR-Altered Advanced Urothelial Carcinoma

    As reported in The New England Journal of Medicine by Loriot et al, a phase II study found the fibroblast growth factor receptor 1-4... Monday July 29, 2019 | The Asco Post
  • Pfizer To Combine Off-patent Drug Business With Mylan

    New York (AFP) - Pfizer announced Monday it will merge its off-patent drug business with generic drugmaker Mylan to create a global leader... Monday July 29, 2019 | ATT.com
  • Pfizer E Mylan Uniscono Le Forze, Nasce Big Dei Farmaci Generici

    Pfizer taglia le guidance del 2019. S&P riduce il rating del gruppo Monday July 29, 2019 | America 24
  • Six Selected For Robert Wood Johnson Foundation Health Policy Fellows Program At NAM

    The National Academy of Medicine (NAM) and Robert Wood Johnson Foundation (RWJF) today named the 2019-2020 class of RWJF Health Policy... Monday July 29, 2019 | EurekAlert!
  • ViiV Healthcare Reicht Zulassungsantrag Bei Der Europäischen Arzneimittelagentur Für Das Prüfpräparat Cabotegravir Zur Anwendung In Kombination Mit Rilpivirin Als Erstes Monatlich Injizierbares Behandlungsregime Für HIV Ein

    Der Marktzulassungsantrag basiert auf den zulassungsrelevanten Phase-III-Studien ATLAS und FLAIR, in denen das einmal monatlich... Monday July 29, 2019 | Business Wire (DE)
  • Body Contouring Devices Market Projected To Reach At A CAGR Of 17.7% By Body Contouring Devices Market Projected To Reach At A CAGR Of 17.7% By | Allergan, Hologic, Bausch Health Companies

    Body contouring devices use different mechanisms such as radiofrequency, laser-assisted lipolysis, ultrasonic assisted lipolysis, and... Monday July 29, 2019 | Prsync.com
  • Consumer Healthcare Market Growth Study By Top Key Players Pfizer, Johnson & Johnson, Abbott Laboratories, Merck, Nestle, Novartis

    Consumer healthcare industry is geared towards improving health conditions for the population and promoting self-responsibility and disease... Monday July 29, 2019 | Hi Tech News Daily.
« Previous 1 … 198 199 200 201 202 … 247 Next »
About Us
  • Who we Are
  • Vision & Mission
  • Charter
  • Advisors
  • Leadership Team
  • Members
  • Contact Us
Focus Geographies
  • China
  • India
  • Japan
  • USA
  • Global
Media & Research
  • News Centre
  • Statistics & Quick Facts
  • Research Report
  • Media Contact
View News Feed
Industry News
  • May 31, 2020
    Opinion: Are we as unbiased as we think?
  • May 31, 2020
    Longtime cancer doctor takes the helm at FDA
  • May 31, 2020
    Charla Huber: Are we as unbiased as we think?
  • May 30, 2020
    Mylan’s Pakistan Partner to Sell Covid-19 Drug Within Two Months
  • May 30, 2020
    Central Maine business briefs: Andrew Zulieve to lead the Maine Bar Association
  • May 29, 2020
    Mylan (MYL) Invalidates Sanofi’s (SNY) Lantus SoloSTAR Device Patents in I
  • May 29, 2020
    Glenmark gets FDA nod for chlorzoxazone
  • May 29, 2020
    The New NAFTA and the End of U.S. Leadership in Trade
  • May 28, 2020
    Redesigning unemployment benefits: A social value-based benefit
  • May 28, 2020
    US: FDA finds carcinogen in some versions of popular diabetes drug
  • May 28, 2020
    FDA Finds Carcinogen in Some Versions of Popular Diabetes Drug
  • May 28, 2020
    Back To Work Wash Hands Wash Face Immunity Protection Detox
  • May 28, 2020
    Regulatory actions for May 27, 2020
  • May 27, 2020
    FDA Finds Carcinogen in Some Versions of Popular Diabetes Drug
  • May 27, 2020
    Clinical trial offers clues about why some metastatic prostate cancers do not re
  • May 27, 2020
    Promising researchers to receive funding through AGA Research Foundation Awards
  • May 27, 2020
    Helium: An Abundant History and a Shortage Threatening Scientific Tools
  • May 27, 2020
    FDA approves 2 drugs to combat COVID-19 shortages
  • May 27, 2020
    ACNM Endorses MANA Health Policy Statement on Passport Denials
  • May 27, 2020
    The Perennial Lessons To Learn From Public Health Policy Battles
  • May 27, 2020
    Lu Qingguo, Chairman Of The National People’S Congress And Chairman Of Che
  • May 27, 2020
    Daewoong Pharmaceutical Acquires Halal Certification for ‘Easyef’ th
  • May 27, 2020
    Does Jones Act protect national security?
  • May 26, 2020
    Takeda’s Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Posi
  • May 26, 2020
    Wired Next Fest, we start with Wired Health
  • May 26, 2020
    Post PCI Bleeding Risk Definition Validated in Real-World Cohort
  • May 25, 2020
    County’s DELCORA moves raise questions
  • May 23, 2020
    Abbott Wins UK Government Contract to Supply Millions of Laboratory-Based IgG An
  • May 23, 2020
    County’s DELCORA moves raise questions
  • May 23, 2020
    Chinese lawmaker suggests improving medical science innovation
  • May 22, 2020
    How will the COVID-19 pandemic end?
  • May 22, 2020
    Filling prescriptions becomes easier for some, harder for others during COVID-19
  • May 22, 2020
    Full text: Premier Li’s Speech At The Third Session Of The 13th NPC
  • May 22, 2020
    Healthgrades COVID-19 Patient Confidence Study Shows Consumer Confidence Towards
  • May 22, 2020
    Full text: Premier Li’s speech at the third session of the 13th NPC
  • May 22, 2020
    Takeda Pharms. U.S.A., Inc. v. Mylan Pharms., Inc.
  • May 21, 2020
    Martin VanTrieste Leads the Way at Civica Rx
  • May 21, 2020
    Abbott SARS-CoV-2 Antibody Test Receives Health Canada Authorization
  • May 21, 2020
    Tarus Therapeutics beefs up its board of directors with a pair of pharmaceutical
  • May 21, 2020
    COVID-19 constraints push healthcare organizations to innovate around the consum
Contact Us
+91-11-43007401 info@chp-f.com https://www.chp-f.com
Follow us
CHP
Copyright © 2023